Business
Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue Projected; Important R&D Updates Expected Following Finalization of Certain Anticipated Transactions
Continues to deliver record revenue and improving operating metricsSignificant expansion in the United States underway, with NOOR and other Sky Premium Life products expected to drive strong profitability supported by gross margins of approximately 75%NOOR Collagen alone is projected to generate more than $12 million in annualized revenue Strong growth expected ahead, driven by organic progress and M&A pipeline including a recent LOI to acquire an $11.5 million pharmacy distribution network Hold
About this update from Cosmos Health Inc.
[{"type":"image","alt":"Cosmos Health Inc.","displaySize":"","headline":null,"caption":"Cosmos Health Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":157,"url":"https://media.zenfs.com/en/globenewswire.com/340010e4b2fe348130647e37170a6c2a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/DHM90zWSRQ5_GKTU6.9fXw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMA--/https://media.zenfs.com/en/globenewswire.com/340010e4b2fe348130647e37170a6c2a","width":300,"height":157}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Continues to deliver record revenue and improving operating metrics","length":67,"tagName":"p"}]},{"val":[{"type":"text","content":"Significant expansion in the United States underway, with NOOR and other Sky Premium Life products expected to drive strong profitability","length":137,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"supported by gross margins of approximately 75%","length":47,"tagName":"p"}]},{"val":[{"type":"text","content":"NOOR Collagen alone is projected to generate more than $12 million in annualized revenue","length":88,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":135,"olType":false}]},{"val":[{"type":"text","content":"Strong growth expected ahead, driven by organic progress and M&A pipeline","length":77,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"including a recent LOI to acquire an $11.5 million pharmacy distribution network","length":80,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":80,"olType":false}]},{"val":[{"type":"text","content":"Holds valuable non-core strategic real estate and digital assets with an estimated fair market value exceeding $18 million, providing meaningful balance sheet flexibility","length":170,"tagName":"p"}]},{"val":[{"type":"text","content":"Evaluating potential monetization of non-core assets to","length":55,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"support more efficient capital allocation","length":41,"tagName":"p"}]},{"val":[{"type":"text","content":"accelerate strategic investments","length":32,"tagName":"p"}]},{"val":[{"type":"text","content":"address the current valuation disconnect, including options such as share repurchases","length":85,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":158,"olType"...